Properly Documenting Early Cell Line Development

In this segment from the Bioprocess Online Live event, “Critical Decisions Driving Next-Generation Cell Line Development,” panelists Ted Peters, Ph.D., and Ronan O’Kennedy, Ph.D., agree that documentation (or rather, failing to document) is the most common issue they’ve encountered teams make in cell line development (CLD). They both believe teams should spend more time correctly documenting early CLD and understanding regulatory requirements ahead of IND submission.